Anal Cancer On the Rise — Study Highlights Most Vulnerable Population
Recent studies are painting a worrying picture: anal cancer, once considered a rare disease, is increasing in incidence in several countries, and it’s not just among the “classic” high-risk groups. New data are identifying demographic shifts that suggest certain populations are particularly vulnerable—and many may be underprotected by current screening or prevention strategies.
—
### What the Data Show
1. **Overall Increasing Incidence and Mortality**
Anal cancer incidence and death rates have been growing steadily in the U.S. and elsewhere. For example, one U.S. study using data from 2001-2015 found annual increases in anal cancer incidence (\~2.7% per year) and mortality (\~3.1% per year).
2. **Shifting Demographics**
Historically, anal cancer has been associated especially with men who have sex with men (MSM), people with HIV, or immunocompromised individuals. Recent reports, however, show that the steepest increases are being seen among:
* **Women aged 65 and older**, particularly White and Hispanic women.
* **Black men and younger men**, especially those with HIV. Some studies point out Black men living with HIV as being among the earliest-onset groups.
3. **Role of HPV (Human Papillomavirus)**
The vast majority of anal cancer cases (often cited around 90%) are linked to high-risk types of HPV infection. ([New York Post][2])
Older women may have missed the opportunity for vaccination (because HPV vaccines were only introduced in the mid-2000s) and are thus more vulnerable now.
4. **Geographic and Social Disparities**
The rise isn’t uniform. Some countries (like the Netherlands, Denmark, UK) have seen large increases over time.
Within the U.S., demographics such as race, socioeconomic status, HIV status, and gender are important risk modifiers.
—
### Who Is Most Vulnerable
Putting all this together, the populations at greatest or rising risk include:
* Women aged **65 and older**, especially White and Hispanic women, who have not had access to HPV vaccination and may not be considered in current screening paradigms.
* People living with HIV, particularly men who have sex with men, because immunodeficiency can lead to persistent HPV infection and greatly elevated risk of anal cancer.
* Black men, especially younger Black men, are experiencing rising rates, possibly due to overlapping risk factors (HPV exposure, HIV infection, health care access) and later presentation/diagnosis.
—
### Why This Matters
* **Prevention Gaps**: Older populations (especially women over 65) were largely ineligible for the HPV vaccines when those were first approved and rolled out. That means they missed a large opportunity for primary prevention.
* **Screening & Awareness**: Unlike cervical cancer, which has well-established screening (Pap smears, HPV tests), there is no widely adopted screening program for anal cancer for the general population. Individuals at high risk are sometimes screened or monitored, but many of the newly identified vulnerable groups are *not* covered by existing screening recommendations.
* **Delayed Diagnosis**: Because anal cancer is still rare and symptoms are often mistaken for benign issues (like hemorrhoids), diagnosis is sometimes delayed, which reduces survival rates.
—
### What Can Be Done
To address the rising trend and protect vulnerable populations, experts suggest:
1. **Expanding HPV vaccination access and uptake**
Vaccinating more people, especially when young, remains the most effective strategy to reduce anal HPV infection and consequently cancer risk. For older individuals who were missed early, increasing awareness of the vaccine’s benefits (where applicable) is also critical.
2. **Tailored screening / surveillance**
Considering whether older women, and other groups with increasing incidence, should be included in anal cancer screening programs or surveillance. Research is ongoing on whether screening for anal precancerous lesions (similar to cervical screening) is effective and feasible.
3. **Raising awareness of symptoms**
Educating health professionals and the public about warning signs (e.g., rectal bleeding, pain, lumps, itching) so cases are diagnosed earlier.
4. **Addressing health disparities**
Ensuring access to care, reducing stigma, improving health literacy, and tackling social determinants like access to preventative services (vaccinations, checkups), especially in marginalized populations (by race, socioeconomic status, HIV status).
—
### Conclusion
Anal cancer trends are showing that “rare” does not mean “stable.” New research indicates that older women—especially those over 65—White and Hispanic, people living with HIV, and younger men (particularly Black men) are being affected more than previously recognized. The disease’s strong link with HPV highlights prevention through vaccination as a cornerstone strategy, but screening and awareness must adapt to cover populations now seeing surges. Mobilizing resources for prevention, early detection, and equitable access to care will be vital if we hope to stem this rising tide.
